Kevin Taylor - Galvanize Therapeutics®
Skip to the content
MENU
Headshot of Kevin Taylor, Chief Operating Officer

Kevin Taylor

Chief Operating Officer

Kevin brings to Galvanize nearly three decades of medical device development, operational experience, and industry leadership. His device development experience spans a range of applications, including joint replacement, cardiovascular intervention, ear nose and throat therapies, and therapeutic energy delivery systems. Kevin also has extensive operational experience in pre-commercial and commercial organizations and has held key management positions in companies including Gala Therapeutics, ReCor Medical, Acclarent, and Guidant (now part of Boston Scientific). Kevin earned his mechanical engineering degree at Drexel University and received his MBA degree from the University of Chicago.

Back to the team

Important Notice:

Galvanize Therapeutics® is a medical device manufacturer, not a healthcare provider. The information submitted through this form will be used solely to connect you with a physician in your area who uses the Aliya® PEF System. Please do not submit protected health information (PHI) — including diagnosis, treatment history, or medical records — through this form.

The Aliya® PEF System (K212871, K233884, and K253826) is 510(k) cleared in the United States for the surgical ablation of soft tissue. Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya PEF System. The Aliya PEF System is a tool for the surgical ablation of soft tissue it is not intended to treat, cure, prevent, nor mitigate any specific disease or condition.

For questions about coverage or eligibility for this procedure, please consult your physician and insurance provider.

I Understand